The Upper Limb Orthosis industry trends over the past 18 months reflect a surge in innovation driven by technological advancements and strategic collaborations. Key developments include partnerships between orthotic manufacturers and AI-driven design platforms, enabling personalized, data-optimized devices. Notably, Ottobock acquired MyoPro, a leader in smart upper-limb orthoses, to enhance its portfolio with sensor-integrated solutions. Meanwhile, Carbon launched a 3D-printed lightweight orthosis, reducing production costs and improving patient comfort. Regulatory shifts, such as the FDAโs expanded guidelines for digital therapeutic devices, have accelerated approvals for smart orthoses with real-time feedback capabilities. Consumer demand is tilting toward customizable and discreet designs, while enterprises prioritize telehealth integration for remote monitoring. Funding activity remains robust, with startups like ReWalk Robotics securing $25M in Series B rounds to scale neurorehabilitation technologies. As aging populations and post-surgical recovery needs rise, the industry is poised to leverage AI, 3D bioprinting, and wearable sensor fusion for next-gen solutions.